Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices

被引:51
|
作者
Ray, Kimberly M. [1 ]
Kerlikowske, Karla [2 ]
Lobach, Iryna V. [2 ]
Hofmann, Michael B. [2 ]
Greenwood, Heather I. [1 ]
Arasu, Vignesh A. [1 ]
Hylton, Nola M. [1 ]
Joe, Bonnie N. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 1600 Divisadero St,Room C250, San Francisco, CA 94115 USA
[2] Univ Calif San Francisco, Dept Med & Epidemiol, 1600 Divisadero St,Room C250, San Francisco, CA 94115 USA
关键词
CONTRAST-MEDIUM ENHANCEMENT; FIBROGLANDULAR TISSUE; FOLLOW-UP; IMPACT; THERAPY; WOMEN; LINE;
D O I
10.1148/radiol.2017170811
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the effect of background parenchymal enhancement (BPE) on breast magnetic resonance (MR)imaging interpretive performance in a large multi-institutional cohort with independent analysis of screening and diagnostic MR studies. Materials and Methods: Analysis of 3770 breast MR studies was conducted. Examinations were performed in 2958 women at six participating facilities in the San Francisco Bay Area from January 2010 to October 2012. Findings were recorded prospectively in the San Francisco Mammography Registry. Performance measures were compared between studies with low BPE (mild or minimal) and those with high BPE (moderate or marked) by using binomial tests of proportions. Results: Of 1726 MR imaging studies in the screening group, 1301 were classified as having low BPE and 425 were classified as having high BPE (75% vs 25%, respectively; P <.001). Of 2044 MR imaging studies in the diagnostic group, 1443 were classified as having low BPE and 601 were classified as having high BPE (71% vs 29%, respectively; P <.001). For low versus high BPE groups at screening, abnormal interpretation rate was 157 of 1301 versus 111 of 424 (12% vs 26%, P <.001); biopsy recommendation rate was 85 of 1301 versus 54 of 424 (7% vs 13%, P <.001); and specificity was 89% (95% confidence interval [CI]: 87, 91) versus 75% (95% CI: 71, 80) (P=.01). For the low versus high BPE groups at diagnostic MR imaging, biopsy recommendation rate was 325 of 1443 versus 195 of 601 (23% vs 32%, P <.001); and specificity was 86% (95% CI: 84, 88) versus 75% (95% CI: 74, 82) (P <.001). There were no significant differences between studies with low versus high BPE in sensitivity for screening (76% [95% CI: 55, 91] vs 83% [95% CI: 52, 98]; P=.94) or diagnostic (93% [95% CI: 87, 97] vs 96% [95% CI: 87, 99]; P=.69) MR imaging, nor were there significant differences in cancer detection rate per 1000 patients between the low BPE versus high BPE groups for screening (15 per 1000 vs 24 per 1000, P=.30) or diagnostic (78 per 1000 vs 85 per 1000, P=.64) MR imaging. Conclusion: Relative to MR studies with minimal or mild BPE, those with moderate or marked BPE were associated with higher abnormal interpretation and biopsy rates and lower specificity, with no difference in cancer detection rate. (C) RSNA, 2017
引用
收藏
页码:822 / 829
页数:8
相关论文
共 50 条
  • [1] Effect of the Menstrual Cycle on Background Parenchymal Enhancement in Breast MR Imaging
    Kajihara, Mariko
    Goto, Mariko
    Hirayama, Yukari
    Okunishi, Shoko
    Kaoku, Setsuko
    Konishi, Eiichi
    Shinkura, Nobuhiko
    MAGNETIC RESONANCE IN MEDICAL SCIENCES, 2013, 12 (01) : 39 - 45
  • [2] Background Parenchymal Enhancement at Breast MR Imaging and Breast Cancer Risk
    King, Valencia
    Brooks, Jennifer D.
    Bernstein, Jonine L.
    Reiner, Anne S.
    Pike, Malcolm C.
    Morris, Elizabeth A.
    RADIOLOGY, 2011, 260 (01) : 50 - 60
  • [3] Effect of Aromatase Inhibitors on Background Parenchymal Enhancement and Amount of Fibroglandular Tissue at Breast MR Imaging
    King, Valencia
    Goldfarb, Shari B.
    Brooks, Jennifer D.
    Sung, Janice S.
    Nulsen, Benjamin F.
    Jozefara, Jolanta E.
    Pike, Malcolm C.
    Dickler, Maura N.
    Morris, Elizabeth A.
    RADIOLOGY, 2012, 264 (03) : 670 - 678
  • [4] Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
    Hu, Xiaoxin
    Jiang, Luan
    You, Chao
    Gu, Yajia
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging
    Sogani, Julie
    Morris, Elizabeth A.
    Kaplan, Jennifer B.
    D'Alessio, Donna
    Goldman, Debra
    Moskowitz, Chaya S.
    Jochelson, Maxine S.
    RADIOLOGY, 2017, 282 (01) : 63 - 73
  • [6] Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging
    Telegrafo, M.
    Rella, L.
    Ianora, A. A. Stabile
    Angelelli, G.
    Moschetta, M.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2016, 97 (03) : 313 - 318
  • [7] Background Parenchymal Enhancement on Breast MRI: Impact on Diagnostic Performance
    DeMartini, Wendy B.
    Liu, Franklin
    Peacock, Sue
    Eby, Peter R.
    Gutierrez, Robert L.
    Lehman, Constance D.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (04) : W373 - W380
  • [8] Is Background Parenchymal Enhancement in Breast Magnetic Resonance Imaging Associated with Breast Cancer?
    Alikhassi, Afsaneh
    Kia, Sona Akbari
    Yazdi, Seyedeh Nooshin Miratashi
    Akbari, Hedieh
    Roozafzai, Farzin
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (05)
  • [9] Analysis of background parenchymal echogenicity on breast ultrasound Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
    Ko, Kyung Hee
    Jung, Hae Kyoung
    Kim, Inwha
    MEDICINE, 2017, 96 (33)
  • [10] Impact of Radiotherapy on Background Parenchymal Enhancement in Breast Magnetic Resonance Imaging
    Kim, Yun Ju
    Kim, Sung Hun
    Choi, Byung Gil
    Kang, Bong Joo
    Kim, Hyeon Sook
    Cha, Eun Suk
    Song, Byung Joo
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (07) : 2939 - 2943